Clinical outcomes following treatment for small saphenous vein insufficiency: An AVLS PRO venous registry study.

IF 1.5 Phlebology Pub Date : 2025-08-01 Epub Date: 2025-02-05 DOI:10.1177/02683555251317854
Carlos Echevarria, Sherry Scovell, John Blebea, Micah Thornton, Julianne Stoughton
{"title":"Clinical outcomes following treatment for small saphenous vein insufficiency: An AVLS PRO venous registry study.","authors":"Carlos Echevarria, Sherry Scovell, John Blebea, Micah Thornton, Julianne Stoughton","doi":"10.1177/02683555251317854","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundCompared to the great saphenous vein, there is a relative paucity of data in the literature focused on treating the small saphenous vein (SSV). Our goal was to evaluate and analyze national registry data related to the diagnosis and treatment of the SSV and identify practice patterns and clinical outcomes.MethodSubjects undergoing SSV interventions between April 2014 and March 2023 were identified in the AVLS PRO Venous Registry. Data points included Clinical, Etiological, Anatomical, Pathological (CEAP) classifications; Venous Clinical Severity Score (VCSS), Venous Quality of Life (VVSymQ®) instrument scores, Heaviness, Aching, Swelling, Throbbing, Itching (HASTI) symptoms, and Short Form Health Survey (SF-36.) Duplex ultrasound findings included vein diameter, length, and the overall recanalization rate.ResultA total of 92,175 SSV interventions were identified. Over two-thirds of subjects presented with a CEAP classification of C3 (31%) and C4 (C4 40%). Clinical results demonstrated significant improvement immediately after treatment in the first month and maintained beneficial results at 1 year or longer (<i>p</i> < 0.001.) This improvement was reflected in the significant decrease in VCSS scores (6 ± 3.4 to 5 ± 2.9; <i>p</i> < 0.0001), VVSymQ (9.5 ± 6.0 to 5.9 ± 4.4; <i>p</i> < 0.0001), and HASTI (9.4 ± 5.9 to 6.6 ± 5.2; <i>p</i> < 0.0001). The recanalization rate at any follow-up was 3%; 48% of those occurring within the first year. Predictors associated with recanalization were larger vein diameter (mean 4.0 mm, 95% CI 3.9-4.1, <i>p</i> < 0.0001) and shorter SSV length (mean 15.27 mm, 95 % CI 14.4-16.1, <i>p</i> < 0.0001).ConclusionTreatment of SSV insufficiency improved clinical outcomes by both patient and physician-derived outcome measures. Only 3% of SSV demonstrated recanalization, and nearly half occurred within the first year following the procedure. Predictors of recanalization included larger pre-procedure vein diameters and treatment of a shorter length of SSV.</p>","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"518-527"},"PeriodicalIF":1.5000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phlebology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/02683555251317854","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/5 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundCompared to the great saphenous vein, there is a relative paucity of data in the literature focused on treating the small saphenous vein (SSV). Our goal was to evaluate and analyze national registry data related to the diagnosis and treatment of the SSV and identify practice patterns and clinical outcomes.MethodSubjects undergoing SSV interventions between April 2014 and March 2023 were identified in the AVLS PRO Venous Registry. Data points included Clinical, Etiological, Anatomical, Pathological (CEAP) classifications; Venous Clinical Severity Score (VCSS), Venous Quality of Life (VVSymQ®) instrument scores, Heaviness, Aching, Swelling, Throbbing, Itching (HASTI) symptoms, and Short Form Health Survey (SF-36.) Duplex ultrasound findings included vein diameter, length, and the overall recanalization rate.ResultA total of 92,175 SSV interventions were identified. Over two-thirds of subjects presented with a CEAP classification of C3 (31%) and C4 (C4 40%). Clinical results demonstrated significant improvement immediately after treatment in the first month and maintained beneficial results at 1 year or longer (p < 0.001.) This improvement was reflected in the significant decrease in VCSS scores (6 ± 3.4 to 5 ± 2.9; p < 0.0001), VVSymQ (9.5 ± 6.0 to 5.9 ± 4.4; p < 0.0001), and HASTI (9.4 ± 5.9 to 6.6 ± 5.2; p < 0.0001). The recanalization rate at any follow-up was 3%; 48% of those occurring within the first year. Predictors associated with recanalization were larger vein diameter (mean 4.0 mm, 95% CI 3.9-4.1, p < 0.0001) and shorter SSV length (mean 15.27 mm, 95 % CI 14.4-16.1, p < 0.0001).ConclusionTreatment of SSV insufficiency improved clinical outcomes by both patient and physician-derived outcome measures. Only 3% of SSV demonstrated recanalization, and nearly half occurred within the first year following the procedure. Predictors of recanalization included larger pre-procedure vein diameters and treatment of a shorter length of SSV.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
小隐静脉功能不全治疗后的临床效果:AVLS PRO 静脉登记研究。
背景:与大隐静脉相比,关于小隐静脉(SSV)治疗的文献资料相对较少。我们的目标是评估和分析与SSV诊断和治疗相关的国家登记数据,并确定实践模式和临床结果。方法:在2014年4月至2023年3月期间接受SSV干预的受试者在AVLS PRO静脉登记处进行识别。数据点包括临床、病因、解剖、病理(CEAP)分类;静脉临床严重程度评分(VCSS)、静脉生活质量(VVSymQ®)仪器评分、沉重、疼痛、肿胀、悸动、瘙痒(HASTI)症状和简短健康调查(SF-36)。双工超声检查结果包括静脉直径、长度和总体再通率。结果:共确定了92,175个SSV干预措施。超过三分之二的受试者CEAP分类为C3(31%)和C4 (C4 40%)。临床结果显示,治疗后第一个月即有显著改善,并在1年或更长时间内保持有益效果(p < 0.001)。这种改善反映在VCSS评分显著下降(6±3.4降至5±2.9;p < 0.0001), VVSymQ(9.5±6.0 ~ 5.9±4.4;p < 0.0001), HASTI(9.4±5.9 ~ 6.6±5.2;P < 0.0001)。每次随访再通率为3%;其中48%发生在第一年。与再通相关的预测因素是较大的静脉直径(平均4.0 mm, 95% CI 3.9-4.1, p < 0.0001)和较短的SSV长度(平均15.27 mm, 95% CI 14.4-16.1, p < 0.0001)。结论:SSV功能不全的治疗通过患者和医生来源的结果测量改善了临床结果。只有3%的SSV表现出再通,近一半发生在手术后的第一年。再通的预测因素包括术前较大的静脉直径和较短的SSV长度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Endovenous welding: Basics and 5-year experience in the use of automatic thermal ablation in the treatment of patients with chronic vein diseases. Iliac vein stent placement in the treatment of pelvic venous disorders in women: A systematic review. Recanalization times in patients with deep vein thrombosis with and without thrombophilia. Comparison of the safety and efficacy between endovenous laser ablation and radiofrequency ablation for great saphenous vein incompetence. Factors influencing the extent of contralateral iliac vein orifice overlap by iliac vein stents.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1